Literature DB >> 22289546

The influence of dietary carbohydrate content on glycaemia in patients with glucokinase maturity-onset diabetes of the young.

T Klupa1, I Solecka, N Nowak, M Szopa, B Kiec-Wilk, J Skupien, I Trybul, B Matejko, W Mlynarski, M T Malecki.   

Abstract

Mutations in the glucokinase (GCK) gene result in maturity-onset diabetes of the young (MODY). Pharmacotherapy is not effective in GCK MODY. Thus, nutritional intervention seems to be the only therapeutic option. This study evaluated the effect of the quantity of dietary carbohydrate on glucose levels in 10 GCK mutation carriers: seven with MODY and three with prediabetes. All patients were exposed to high-carbohydrate diets for 2 days and then switched to low-carbohydrate diets (60% versus 25% of the daily calorie intake) for another 2 days, after a 1-day washout. Glucose levels were assessed by continuous blood glucose monitoring. In patients with GCK MODY on high-carbohydrate diets, glucose levels were significantly higher, and more hyperglycaemic episodes occurred, compared with patients on low-carbohydrate diets. This short-term observational study suggested that diets with a modestly limited carbohydrate content may improve glycaemic control in patients with GCK MODY.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22289546     DOI: 10.1177/147323001103900627

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  2 in total

Review 1.  The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY).

Authors:  Ken Munene Nkonge; Dennis Karani Nkonge; Teresa Njeri Nkonge
Journal:  Clin Diabetes Endocrinol       Date:  2020-11-04

2.  Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes.

Authors:  Magdalena Szopa; Maria Kapusta; Bartlomiej Matejko; Tomasz Klupa; Teresa Koblik; Beata Kiec-Wilk; Maciej Borowiec; Maciej T Malecki
Journal:  J Diabetes Res       Date:  2015-08-10       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.